Answer
Xigduo (dapagliflozin/metformin) has no or negligible influence on driving or using machines, but patients should be alerted to hypoglycaemia risk when it is combined with other glucose-lowering medicines known to cause hypoglycaemia.
Sources for this answer
- Xigduo 5 mg/850 mg film-coated tabletsAstraZeneca UK Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 27Document updated
Sources checked